theratrame

THERAtRAME was founded in 2022 based on new knowledge in tRNA epitranscriptomics resulting from more than a decade of fundamental research in the laboratories of Alain Chariot, Francesca Rapino and Pierre Close.

 

th-1024x0-cmd-coat.png
 

CMD-Coat was founded in 202 and resulted from research in the Cardiology laboratory of Patrizio Lancellotti and Cécile Oury. The research team has developed an innovative bio- and hemo-compatible coating, which can be loaded with drugs, called Coatigel.

Share this page